{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:30:47Z","timestamp":1784957447940,"version":"3.55.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T00:00:00Z","timestamp":1418860800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0115401","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T08:10:54Z","timestamp":1418976654000},"page":"e115401","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":91,"title":["Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation"],"prefix":"10.1371","volume":"9","author":[{"given":"Xiu","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Shan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2008.09.001","article-title":"Melanoma epidemiology and trends","volume":"27","author":"C Garbe","year":"2009","journal-title":"Clin Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2004.05708.x","article-title":"Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma","volume":"150","author":"MB Lens","year":"2004","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.2004.04.165","article-title":"Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study","volume":"22","author":"MF Avril","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.ejca.2013.06.027","article-title":"Recent advances in melanoma systemic therapy, BRAF inhibitors, CTLA4 antibodies and beyond","volume":"49","author":"AM Menzies","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09546634.2013.813897","article-title":"Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2","volume":"25","author":"C Ma","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"S Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s13238-013-0010-3","article-title":"Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulatethe motility of pancreatic cancer cells","volume":"5","author":"DW Li","year":"2014","journal-title":"Protein Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1158\/1078-0432.CCR-04-0455","article-title":"HDAC6 expression is correlated with better survival in breast cancer","volume":"10","author":"ZH Zhang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.cdd.4401567","article-title":"Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1\/WAF1 expression, independent of histone deacetylase 1","volume":"12","author":"BH Huang","year":"2005","journal-title":"Cell Death Differ"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0463.2005.apm_04.x","article-title":"Increased expression of histone deacetylase 2 is found in human gastric cancer","volume":"113","author":"J Song","year":"2005","journal-title":"APMIS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"I Oehme","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.lungcan.2005.02.006","article-title":"Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma","volume":"49","author":"B Bartling","year":"2005","journal-title":"Lung Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1074\/jbc.M510023200","article-title":"Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer","volume":"281","author":"AJ Wilson","year":"2006","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"W Weichert","year":"2009","journal-title":"Cancer lett"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s13238-011-1063-9","article-title":"The impact of acetylation and deacetylation on the p53 pathway","volume":"2","author":"CL Brooks","year":"2011","journal-title":"Protein Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"20436","DOI":"10.1074\/jbc.M000202200","article-title":"Histone deacetylases specifically downregulate p53-dependent gene activation","volume":"275","author":"LJ Juan","year":"2000","journal-title":"J Biol Chem"},{"key":"ref17","first-page":"680","article-title":"Histone deacetylase 3 (HDAC3) as a novel therapeutic target in multiple myeloma","volume":"3","author":"J Minami","year":"2013","journal-title":"Leukemia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13277-010-0066-0","article-title":"Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung","volume":"31","author":"Y Minamiya","year":"2010","journal-title":"Tumor Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"PA Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1517\/13543784.2011.629604","article-title":"Belinostat: clinical applications in solid tumors and lymphoma","volume":"20","author":"LR Molife","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1358\/dot.2014.50.5.2138703","article-title":"Belinostat for the treatment of peripheral T-cell lymphomas","volume":"50","author":"J McDermott","year":"2014","journal-title":"Drugs Today (Barc)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.09.018","article-title":"Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer","volume":"329","author":"HVK Diyabalanage","year":"2013","journal-title":"Cancer Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1535-7163.MCT-12-0054","article-title":"Sensitization of TRAIL-induced cell death by 20(S)-Ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells","volume":"12","author":"JY Lee","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jgr.2013.11.007","article-title":"Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell","volume":"38","author":"EH Park","year":"2014","journal-title":"J Ginseng Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2012.02.040","article-title":"Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells","volume":"683","author":"XY Pan","year":"2012","journal-title":"European J Pharmacol"},{"key":"ref26","first-page":"254","article-title":"A randomized, prospective, muti-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients","volume":"9","author":"Y Sun","year":"2006","journal-title":"CJLC"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1158\/0008-5472.CAN-09-1099","article-title":"De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation","volume":"69","author":"JW Liu","year":"2009","journal-title":"Cancer Res"},{"key":"ref28","first-page":"63","article-title":"(2014) Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma","volume":"9","author":"M Laura","journal-title":"Targ Oncol"},{"key":"ref29","first-page":"510","article-title":"Adverse skin reactions induced by BRAF inhibitors: A systematic review","volume":"140","author":"V Sibaud","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s12272-009-1515-4","article-title":"Inhibition of NF-\u03baB by Ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel","volume":"32","author":"SM Kim","year":"2009","journal-title":"Arch Pharm Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.fct.2012.01.005","article-title":"Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1\/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species","volume":"50","author":"CK Lee","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2009.08.008","article-title":"KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice","volume":"289","author":"JH Yoo","year":"2010","journal-title":"Cancer Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2407-9-250","article-title":"Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice","volume":"9","author":"TG Liu","year":"2009","journal-title":"BMC Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2013.02.007","article-title":"HDAC3 regulates stability of estrogen receptor a mRNA","volume":"432","author":"S Oie","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-013-1762-z","article-title":"Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2\/miR-15a\/16-1 via HDAC3 in non-small cell lung cancer","volume":"383","author":"CQ Chen","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"ref36","first-page":"ra80","article-title":"DNMT1 Stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination","volume":"3","author":"ZW Du","year":"2010","journal-title":"Sci signal"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e30815","DOI":"10.1371\/journal.pone.0030815","article-title":"Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models","volume":"7","author":"L Shen","year":"2012","journal-title":"PLoS One"},{"key":"ref38","first-page":"793","article-title":"Post-translational modification of p53 in tumorigenesis","volume":"4","author":"AM Bode","year":"2004","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","article-title":"Modes of p53 regulation","volume":"137","author":"JP Kruse","year":"2009","journal-title":"Cell"},{"key":"ref40","first-page":"353","article-title":"Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases","volume":"41","author":"VS Thakur","year":"2012","journal-title":"Int J Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/MCB.26.7.2782-2790.2006","article-title":"Acetylation of p53 at lysine 373\/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21<sup>Waf1\/Cip1<\/sup>","volume":"26","author":"SL ZhaoY, Lu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"50607","DOI":"10.1074\/jbc.C200578200","article-title":"Acetylation of p53 inhibits its ubiquitination by mdm2","volume":"277","author":"MY Li","year":"2002","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/emboj\/20.6.1331","article-title":"p300\/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2","volume":"20","author":"A Ito","year":"2001","journal-title":"EMBO J"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.2011.532","article-title":"Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide","volume":"106","author":"J Chang","year":"2012","journal-title":"Br J Cancer"},{"key":"ref45","first-page":"55","article-title":"Epigenetic regulation of the TRAIL\/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance","volume":"2","author":"AR Jazirehi","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1038\/cddis.2013.192","article-title":"Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3","volume":"4","author":"F Lai","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.cgt.7700551","article-title":"A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma","volume":"10","author":"SJ Yamamoto","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.leukres.2012.07.002","article-title":"Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192","volume":"36","author":"M Boissinot","year":"2012","journal-title":"Leuk Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00109-012-0932-x","article-title":"Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells","volume":"91","author":"LF Feng","year":"2012","journal-title":"J Mol Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0115401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:04:14Z","timestamp":1589007854000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0115401"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,18]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0115401","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,18]]}}}